ID   TNIK_HUMAN              Reviewed;        1360 AA.
AC   Q9UKE5; A7E2A3; A8K4U1; D3DNQ6; O60298; Q8WUY7; Q9UKD8; Q9UKD9; Q9UKE0;
AC   Q9UKE1; Q9UKE2; Q9UKE3; Q9UKE4;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   12-OCT-2022, entry version 207.
DE   RecName: Full=TRAF2 and NCK-interacting protein kinase;
DE            EC=2.7.11.1;
GN   Name=TNIK; Synonyms=KIAA0551;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAF03782.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7 AND 8), FUNCTION,
RP   TISSUE SPECIFICITY, INTERACTION WITH TRAF2 AND NCK, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=10521462; DOI=10.1074/jbc.274.43.30729;
RA   Fu C.A., Shen M., Huang B.C., Lasaga J., Payan D.G., Luo Y.;
RT   "TNIK, a novel member of the germinal center kinase family that activates
RT   the c-Jun N-terminal kinase pathway and regulates the cytoskeleton.";
RL   J. Biol. Chem. 274:30729-30737(1999).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3] {ECO:0000305}
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-769, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [9]
RP   FUNCTION, INTERACTION WITH RAP2A, SUBCELLULAR LOCATION,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-54.
RX   PubMed=15342639; DOI=10.1074/jbc.m406370200;
RA   Taira K., Umikawa M., Takei K., Myagmar B.-E., Shinzato M., Machida N.,
RA   Uezato H., Nonaka S., Kariya K.;
RT   "The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to
RT   regulate actin cytoskeleton.";
RL   J. Biol. Chem. 279:49488-49496(2004).
RN   [10]
RP   INTERACTION WITH TANC1.
RX   PubMed=18930710; DOI=10.1016/j.bbrc.2008.10.038;
RA   Nonaka H., Takei K., Umikawa M., Oshiro M., Kuninaka K., Bayarjargal M.,
RA   Asato T., Yamashiro Y., Uechi Y., Endo S., Suzuki T., Kariya K.;
RT   "MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold
RT   protein TANC1.";
RL   Biochem. Biophys. Res. Commun. 377:573-578(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640 AND SER-769, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640; SER-688; SER-720 AND
RP   SER-769, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-678 AND SER-680, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19061864; DOI=10.1016/j.bbrc.2008.11.107;
RA   Uechi Y., Bayarjargal M., Umikawa M., Oshiro M., Takei K., Yamashiro Y.,
RA   Asato T., Endo S., Misaki R., Taguchi T., Kariya K.;
RT   "Rap2 function requires palmitoylation and recycling endosome
RT   localization.";
RL   Biochem. Biophys. Res. Commun. 378:732-737(2009).
RN   [16]
RP   SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, MUTAGENESIS OF LYS-54;
RP   152-ARG-ASP-153 AND 171-ASP-PHE-172, INTERACTION WITH TCF7L2 AND CTNNB1,
RP   TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=19816403; DOI=10.1038/emboj.2009.285;
RA   Mahmoudi T., Li V.S.W., Ng S.S., Taouatas N., Vries R.G.J., Mohammed S.,
RA   Heck A.J., Clevers H.;
RT   "The kinase TNIK is an essential activator of Wnt target genes.";
RL   EMBO J. 28:3329-3340(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560; SER-640; SER-688;
RP   SER-707; SER-720; SER-766 AND SER-769, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH NEDD4 AND RAP2A.
RX   PubMed=20159449; DOI=10.1016/j.neuron.2010.01.007;
RA   Kawabe H., Neeb A., Dimova K., Young S.M. Jr., Takeda M.,
RA   Katsurabayashi S., Mitkovski M., Malakhova O.A., Zhang D.E., Umikawa M.,
RA   Kariya K., Goebbels S., Nave K.A., Rosenmund C., Jahn O., Rhee J.,
RA   Brose N.;
RT   "Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite
RT   development.";
RL   Neuron 65:358-372(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   FUNCTION.
RX   PubMed=21690388; DOI=10.1073/pnas.1104128108;
RA   Kaneko S., Chen X., Lu P., Yao X., Wright T.G., Rajurkar M., Kariya K.,
RA   Mao J., Ip Y.T., Xu L.;
RT   "Smad inhibition by the Ste20 kinase Misshapen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11127-11132(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-688 AND SER-769, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; SER-600; SER-608;
RP   SER-610; SER-640; SER-678; SER-680; SER-688; SER-701; SER-707; SER-720;
RP   SER-764; SER-769 AND SER-959, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640 AND SER-680, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   POSSIBLE INVOLVEMENT IN MRT54.
RX   PubMed=27106596; DOI=10.1007/s00439-016-1671-9;
RA   Anazi S., Shamseldin H.E., AlNaqeb D., Abouelhoda M., Monies D.,
RA   Salih M.A., Al-Rubeaan K., Alkuraya F.S.;
RT   "A null mutation in TNIK defines a novel locus for intellectual
RT   disability.";
RL   Hum. Genet. 135:773-778(2016).
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-778; GLU-910 AND THR-999.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase that acts as an essential activator
CC       of the Wnt signaling pathway. Recruited to promoters of Wnt target
CC       genes and required to activate their expression. May act by
CC       phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-
CC       terminal pathway. May play a role in the response to environmental
CC       stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK
CC       which regulates neuronal dendrite extension and arborization during
CC       development. More generally, it may play a role in cytoskeletal
CC       rearrangements and regulate cell spreading. Phosphorylates SMAD1 on
CC       Thr-322. {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:15342639,
CC       ECO:0000269|PubMed:19061864, ECO:0000269|PubMed:19816403,
CC       ECO:0000269|PubMed:20159449, ECO:0000269|PubMed:21690388}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:10521462};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10521462};
CC   -!- SUBUNIT: Interacts (via the CNH domain) with RAP2A (GTP-bound form
CC       preferentially); the interaction is direct and required for the
CC       activation of TNIK by RAP2A. Interacts with NEDD4; recruits RAP2A to
CC       NEDD4. Interacts with TRAF2 and NCK. Interacts with TCF7L2/TCF4 and
CC       CTNNB1; the interaction is direct. Interacts with TANC1.
CC       {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:15342639,
CC       ECO:0000269|PubMed:18930710, ECO:0000269|PubMed:19816403,
CC       ECO:0000269|PubMed:20159449}.
CC   -!- INTERACTION:
CC       Q9UKE5; P35222: CTNNB1; NbExp=3; IntAct=EBI-1051794, EBI-491549;
CC       Q9UKE5; Q9NRI5: DISC1; NbExp=4; IntAct=EBI-1051794, EBI-529989;
CC       Q9UKE5; O14920: IKBKB; NbExp=2; IntAct=EBI-1051794, EBI-81266;
CC       Q9UKE5; O43318: MAP3K7; NbExp=3; IntAct=EBI-1051794, EBI-358684;
CC       Q9UKE5; Q9NYJ8: TAB2; NbExp=3; IntAct=EBI-1051794, EBI-358708;
CC       Q9UKE5; Q9NQB0: TCF7L2; NbExp=3; IntAct=EBI-1051794, EBI-924724;
CC       Q9UKE5; Q12933: TRAF2; NbExp=2; IntAct=EBI-1051794, EBI-355744;
CC       Q9UKE5; Q9Y4K3: TRAF6; NbExp=3; IntAct=EBI-1051794, EBI-359276;
CC       Q9UKE5; P03230: LMP1; Xeno; NbExp=7; IntAct=EBI-1051794, EBI-6973030;
CC       Q9UKE5; Q6F6B3: Tanc1; Xeno; NbExp=2; IntAct=EBI-1051794, EBI-2133582;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Recycling endosome.
CC       Cytoplasm, cytoskeleton. Note=Associated with recycling endosomes and
CC       the cytoskeletal fraction upon RAP2A overexpression.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=Q9UKE5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKE5-2; Sequence=VSP_004889;
CC       Name=3;
CC         IsoId=Q9UKE5-3; Sequence=VSP_004890;
CC       Name=4;
CC         IsoId=Q9UKE5-4; Sequence=VSP_004891;
CC       Name=5;
CC         IsoId=Q9UKE5-5; Sequence=VSP_004889, VSP_004890;
CC       Name=6;
CC         IsoId=Q9UKE5-6; Sequence=VSP_004889, VSP_004891;
CC       Name=7;
CC         IsoId=Q9UKE5-7; Sequence=VSP_004890, VSP_004891;
CC       Name=8;
CC         IsoId=Q9UKE5-8; Sequence=VSP_004889, VSP_004890, VSP_004891;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously. Highest levels observed in
CC       heart, brain and skeletal muscle. Expressed in normal colonic epithelia
CC       and colorectal cancer tissues. {ECO:0000269|PubMed:10521462,
CC       ECO:0000269|PubMed:19816403}.
CC   -!- PTM: Autophosphorylated. Autophosphorylation is activated by RAP2A and
CC       induces association to the cytoskeletal fraction.
CC   -!- DISEASE: Intellectual developmental disorder, autosomal recessive 54
CC       (MRT54) [MIM:617028]: A disorder characterized by significantly below
CC       average general intellectual functioning associated with impairments in
CC       adaptive behavior and manifested during the developmental period. MRT54
CC       patients manifest intellectual disability, delayed speech and
CC       hyperactivity. {ECO:0000269|PubMed:27106596}. Note=The disease may be
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25477.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF172264; AAF03782.1; -; mRNA.
DR   EMBL; AF172268; AAF03786.1; -; mRNA.
DR   EMBL; AF172267; AAF03785.1; -; mRNA.
DR   EMBL; AF172266; AAF03784.1; -; mRNA.
DR   EMBL; AF172265; AAF03783.1; -; mRNA.
DR   EMBL; AF172270; AAF03788.1; -; mRNA.
DR   EMBL; AF172271; AAF03789.1; -; mRNA.
DR   EMBL; AF172269; AAF03787.1; -; mRNA.
DR   EMBL; AB011123; BAA25477.2; ALT_INIT; mRNA.
DR   EMBL; AK291056; BAF83745.1; -; mRNA.
DR   EMBL; AC026315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078793; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC137517; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78484.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78489.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78492.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78493.1; -; Genomic_DNA.
DR   EMBL; BC019081; AAH19081.2; -; mRNA.
DR   EMBL; BC150256; AAI50257.1; -; mRNA.
DR   CCDS; CCDS46956.1; -. [Q9UKE5-1]
DR   CCDS; CCDS54673.1; -. [Q9UKE5-8]
DR   CCDS; CCDS54674.1; -. [Q9UKE5-5]
DR   CCDS; CCDS54675.1; -. [Q9UKE5-6]
DR   CCDS; CCDS54676.1; -. [Q9UKE5-2]
DR   CCDS; CCDS54677.1; -. [Q9UKE5-7]
DR   CCDS; CCDS54678.1; -. [Q9UKE5-3]
DR   CCDS; CCDS54679.1; -. [Q9UKE5-4]
DR   RefSeq; NP_001155032.1; NM_001161560.2. [Q9UKE5-4]
DR   RefSeq; NP_001155033.1; NM_001161561.2. [Q9UKE5-2]
DR   RefSeq; NP_001155034.1; NM_001161562.2. [Q9UKE5-6]
DR   RefSeq; NP_001155035.1; NM_001161563.2. [Q9UKE5-3]
DR   RefSeq; NP_001155036.1; NM_001161564.2. [Q9UKE5-7]
DR   RefSeq; NP_001155037.1; NM_001161565.2. [Q9UKE5-5]
DR   RefSeq; NP_001155038.1; NM_001161566.2. [Q9UKE5-8]
DR   RefSeq; NP_055843.1; NM_015028.3. [Q9UKE5-1]
DR   PDB; 2X7F; X-ray; 2.80 A; A/B/C/D/E=1-325.
DR   PDB; 5AX9; X-ray; 2.40 A; A/B/C=11-314.
DR   PDB; 5CWZ; X-ray; 2.90 A; A/B/C=11-314.
DR   PDB; 5D7A; X-ray; 2.90 A; A/B/C=11-314.
DR   PDB; 6RA5; X-ray; 2.90 A; A/B=11-314.
DR   PDB; 6RA7; X-ray; 1.20 A; A=11-314.
DR   PDBsum; 2X7F; -.
DR   PDBsum; 5AX9; -.
DR   PDBsum; 5CWZ; -.
DR   PDBsum; 5D7A; -.
DR   PDBsum; 6RA5; -.
DR   PDBsum; 6RA7; -.
DR   AlphaFoldDB; Q9UKE5; -.
DR   SMR; Q9UKE5; -.
DR   BioGRID; 116682; 113.
DR   DIP; DIP-37562N; -.
DR   IntAct; Q9UKE5; 162.
DR   MINT; Q9UKE5; -.
DR   STRING; 9606.ENSP00000399511; -.
DR   BindingDB; Q9UKE5; -.
DR   ChEMBL; CHEMBL4527; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9UKE5; -.
DR   GuidetoPHARMACOLOGY; 2244; -.
DR   GlyGen; Q9UKE5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UKE5; -.
DR   PhosphoSitePlus; Q9UKE5; -.
DR   SwissPalm; Q9UKE5; -.
DR   BioMuta; TNIK; -.
DR   DMDM; 29840818; -.
DR   EPD; Q9UKE5; -.
DR   jPOST; Q9UKE5; -.
DR   MassIVE; Q9UKE5; -.
DR   MaxQB; Q9UKE5; -.
DR   PaxDb; Q9UKE5; -.
DR   PeptideAtlas; Q9UKE5; -.
DR   PRIDE; Q9UKE5; -.
DR   ProteomicsDB; 84769; -. [Q9UKE5-1]
DR   ProteomicsDB; 84770; -. [Q9UKE5-2]
DR   ProteomicsDB; 84771; -. [Q9UKE5-3]
DR   ProteomicsDB; 84772; -. [Q9UKE5-4]
DR   ProteomicsDB; 84773; -. [Q9UKE5-5]
DR   ProteomicsDB; 84774; -. [Q9UKE5-6]
DR   ProteomicsDB; 84775; -. [Q9UKE5-7]
DR   ProteomicsDB; 84776; -. [Q9UKE5-8]
DR   Antibodypedia; 2086; 565 antibodies from 32 providers.
DR   DNASU; 23043; -.
DR   Ensembl; ENST00000284483.12; ENSP00000284483.8; ENSG00000154310.17. [Q9UKE5-4]
DR   Ensembl; ENST00000341852.10; ENSP00000345352.6; ENSG00000154310.17. [Q9UKE5-5]
DR   Ensembl; ENST00000357327.9; ENSP00000349880.5; ENSG00000154310.17. [Q9UKE5-2]
DR   Ensembl; ENST00000436636.7; ENSP00000399511.2; ENSG00000154310.17. [Q9UKE5-1]
DR   Ensembl; ENST00000460047.5; ENSP00000418916.1; ENSG00000154310.17. [Q9UKE5-7]
DR   Ensembl; ENST00000470834.5; ENSP00000419990.1; ENSG00000154310.17. [Q9UKE5-6]
DR   Ensembl; ENST00000475336.5; ENSP00000418156.1; ENSG00000154310.17. [Q9UKE5-8]
DR   Ensembl; ENST00000488470.5; ENSP00000418378.1; ENSG00000154310.17. [Q9UKE5-3]
DR   GeneID; 23043; -.
DR   KEGG; hsa:23043; -.
DR   MANE-Select; ENST00000436636.7; ENSP00000399511.2; NM_015028.4; NP_055843.1.
DR   UCSC; uc003fhh.3; human. [Q9UKE5-1]
DR   CTD; 23043; -.
DR   DisGeNET; 23043; -.
DR   GeneCards; TNIK; -.
DR   HGNC; HGNC:30765; TNIK.
DR   HPA; ENSG00000154310; Tissue enhanced (brain).
DR   MalaCards; TNIK; -.
DR   MIM; 610005; gene.
DR   MIM; 617028; phenotype.
DR   neXtProt; NX_Q9UKE5; -.
DR   OpenTargets; ENSG00000154310; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   PharmGKB; PA134893180; -.
DR   VEuPathDB; HostDB:ENSG00000154310; -.
DR   eggNOG; KOG0587; Eukaryota.
DR   GeneTree; ENSGT00950000183196; -.
DR   InParanoid; Q9UKE5; -.
DR   OMA; VSTHAQE; -.
DR   OrthoDB; 533537at2759; -.
DR   PhylomeDB; Q9UKE5; -.
DR   TreeFam; TF105138; -.
DR   PathwayCommons; Q9UKE5; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   SignaLink; Q9UKE5; -.
DR   SIGNOR; Q9UKE5; -.
DR   BioGRID-ORCS; 23043; 13 hits in 1114 CRISPR screens.
DR   ChiTaRS; TNIK; human.
DR   EvolutionaryTrace; Q9UKE5; -.
DR   GeneWiki; TNIK; -.
DR   GenomeRNAi; 23043; -.
DR   Pharos; Q9UKE5; Tchem.
DR   PRO; PR:Q9UKE5; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9UKE5; protein.
DR   Bgee; ENSG00000154310; Expressed in cortical plate and 190 other tissues.
DR   ExpressionAtlas; Q9UKE5; baseline and differential.
DR   Genevisible; Q9UKE5; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IEA:Ensembl.
DR   GO; GO:0098793; C:presynapse; IEA:Ensembl.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; IBA:GO_Central.
DR   GO; GO:0030033; P:microvillus assembly; IMP:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; IDA:UniProtKB.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0010243; P:response to organonitrogen compound; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm; Cytoskeleton;
KW   Endosome; Intellectual disability; Kinase; Neurogenesis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Wnt signaling pathway.
FT   CHAIN           1..1360
FT                   /note="TRAF2 and NCK-interacting protein kinase"
FT                   /id="PRO_0000086761"
FT   DOMAIN          25..289
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          1047..1334
FT                   /note="CNH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00795"
FT   REGION          284..347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          290..1047
FT                   /note="Mediates interaction with NEDD4"
FT                   /evidence="ECO:0000269|PubMed:20159449"
FT   REGION          398..440
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          539..589
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          601..801
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          814..878
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          908..927
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          933..998
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        288..320
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        321..336
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        563..577
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        602..647
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        656..670
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        671..687
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        719..759
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        776..801
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        814..831
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        834..849
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        933..981
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        153
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         31..39
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         54
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         187
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P83510"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P83510"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         570
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         581
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P83510"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         608
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         610
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18088087,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         678
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         680
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         688
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         701
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         707
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         720
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:23186163"
FT   MOD_RES         764
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         766
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         769
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15144186,
FT                   ECO:0007744|PubMed:18088087, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         959
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         445..473
FT                   /note="Missing (in isoform 2, isoform 5, isoform 6 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10521462,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_004889"
FT   VAR_SEQ         537..591
FT                   /note="Missing (in isoform 3, isoform 5, isoform 7 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10521462,
FT                   ECO:0000303|PubMed:14702039"
FT                   /id="VSP_004890"
FT   VAR_SEQ         795..802
FT                   /note="Missing (in isoform 4, isoform 6, isoform 7 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:10521462"
FT                   /id="VSP_004891"
FT   VARIANT         778
FT                   /note="K -> E (in dbSNP:rs55778284)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041231"
FT   VARIANT         910
FT                   /note="G -> E (in dbSNP:rs35090763)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041232"
FT   VARIANT         999
FT                   /note="A -> T (in dbSNP:rs17857452)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041233"
FT   MUTAGEN         54
FT                   /note="K->A: Kinase dead. Loss of autophosphorylation and
FT                   loss of function in cytoskeleton regulation."
FT                   /evidence="ECO:0000269|PubMed:15342639,
FT                   ECO:0000269|PubMed:19816403"
FT   MUTAGEN         152..153
FT                   /note="RD->AA: Loss of autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:19816403"
FT   MUTAGEN         171..172
FT                   /note="DF->AA: Loss of autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:19816403"
FT   HELIX           15..17
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            22..24
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          25..31
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           32..34
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          37..44
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            45..47
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          50..58
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            60..62
FT                   /evidence="ECO:0007829|PDB:5AX9"
FT   HELIX           63..76
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          85..91
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:5AX9"
FT   STRAND          99..106
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           113..118
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           121..123
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           127..146
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           156..158
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          159..161
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            173..175
FT                   /evidence="ECO:0007829|PDB:2X7F"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           197..200
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            201..204
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           213..228
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            232..235
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           238..244
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   TURN            245..247
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   STRAND          256..258
FT                   /evidence="ECO:0007829|PDB:6RA5"
FT   HELIX           260..269
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           274..276
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           280..284
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           287..290
FT                   /evidence="ECO:0007829|PDB:6RA7"
FT   HELIX           295..313
FT                   /evidence="ECO:0007829|PDB:6RA7"
SQ   SEQUENCE   1360 AA;  154943 MW;  3590BC2905A72C3D CRC64;
     MASDSPARSL DEIDLSALRD PAGIFELVEL VGNGTYGQVY KGRHVKTGQL AAIKVMDVTG
     DEEEEIKQEI NMLKKYSHHR NIATYYGAFI KKNPPGMDDQ LWLVMEFCGA GSVTDLIKNT
     KGNTLKEEWI AYICREILRG LSHLHQHKVI HRDIKGQNVL LTENAEVKLV DFGVSAQLDR
     TVGRRNTFIG TPYWMAPEVI ACDENPDATY DFKSDLWSLG ITAIEMAEGA PPLCDMHPMR
     ALFLIPRNPA PRLKSKKWSK KFQSFIESCL VKNHSQRPAT EQLMKHPFIR DQPNERQVRI
     QLKDHIDRTK KKRGEKDETE YEYSGSEEEE EENDSGEPSS ILNLPGESTL RRDFLRLQLA
     NKERSEALRR QQLEQQQREN EEHKRQLLAE RQKRIEEQKE QRRRLEEQQR REKELRKQQE
     REQRRHYEEQ MRREEERRRA EHEQEYIRRQ LEEEQRQLEI LQQQLLHEQA LLLEYKRKQL
     EEQRQAERLQ RQLKQERDYL VSLQHQRQEQ RPVEKKPLYH YKEGMSPSEK PAWAKEVEER
     SRLNRQSSPA MPHKVANRIS DPNLPPRSES FSISGVQPAR TPPMLRPVDP QIPHLVAVKS
     QGPALTASQS VHEQPTKGLS GFQEALNVTS HRVEMPRQNS DPTSENPPLP TRIEKFDRSS
     WLRQEEDIPP KVPQRTTSIS PALARKNSPG NGSALGPRLG SQPIRASNPD LRRTEPILES
     PLQRTSSGSS SSSSTPSSQP SSQGGSQPGS QAGSSERTRV RANSKSEGSP VLPHEPAKVK
     PEESRDITRP SRPASYKKAI DEDLTALAKE LRELRIEETN RPMKKVTDYS SSSEESESSE
     EEEEDGESET HDGTVAVSDI PRLIPTGAPG SNEQYNVGMV GTHGLETSHA DSFSGSISRE
     GTLMIRETSG EKKRSGHSDS NGFAGHINLP DLVQQSHSPA GTPTEGLGRV STHSQEMDSG
     TEYGMGSSTK ASFTPFVDPR VYQTSPTDED EEDEESSAAA LFTSELLRQE QAKLNEARKI
     SVVNVNPTNI RPHSDTPEIR KYKKRFNSEI LCAALWGVNL LVGTENGLML LDRSGQGKVY
     NLINRRRFQQ MDVLEGLNVL VTISGKKNKL RVYYLSWLRN RILHNDPEVE KKQGWITVGD
     LEGCIHYKVV KYERIKFLVI ALKNAVEIYA WAPKPYHKFM AFKSFADLQH KPLLVDLTVE
     EGQRLKVIFG SHTGFHVIDV DSGNSYDIYI PSHIQGNITP HAIVILPKTD GMEMLVCYED
     EGVYVNTYGR ITKDVVLQWG EMPTSVAYIH SNQIMGWGEK AIEIRSVETG HLDGVFMHKR
     AQRLKFLCER NDKVFFASVR SGGSSQVFFM TLNRNSMMNW
//
